Children of mothers treated with adalimumab or infliximab for inflammatory bowel disease should have any live vaccines delayed until they are at least 12 months old, Australasian research concludes. Among 80 mothers and their children, cord blood levels of adalimumab at birth were 21% higher than the mothers’ blood levels, and levels of infliximab were ...
Delay live vaccines after TNF inhibitors during pregnancy
By Tony James
14 Apr 2016